121 related articles for article (PubMed ID: 29284287)
1. Recombinant Adenovirus-p53 Gene Therapy for Advanced Unresectable Soft-Tissue Sarcomas.
Xiao SW; Xu YZ; Xiao BF; Jiang J; Liu CQ; Fang ZW; Li DM; Li XF; Cai Y; Li YH; Sun Y; Su X; Zhu GY; Zhang SW
Hum Gene Ther; 2018 Jun; 29(6):699-707. PubMed ID: 29284287
[TBL] [Abstract][Full Text] [Related]
2. Effect and Safety of Recombinant Adenovirus-p53 Transfer Combined with Radiotherapy on Long-Term Survival of Locally Advanced Cervical Cancer.
Su X; Chen WJ; Xiao SW; Li XF; Xu G; Pan JJ; Zhang SW
Hum Gene Ther; 2016 Dec; 27(12):1008-1014. PubMed ID: 27575731
[TBL] [Abstract][Full Text] [Related]
3. Effect of recombinant adenovirus-p53 combined with radiotherapy on long-term prognosis of advanced nasopharyngeal carcinoma.
Pan JJ; Zhang SW; Chen CB; Xiao SW; Sun Y; Liu CQ; Su X; Li DM; Xu G; Xu B; Lu YY
J Clin Oncol; 2009 Feb; 27(5):799-804. PubMed ID: 19103729
[TBL] [Abstract][Full Text] [Related]
4. Recombinant adenovirus p53 combined with radiotherapy improves efficacy and safety in the treatment of head and neck lymphoma.
Xu YH; Liu SH; Hao FR; Zhang YH
Cancer Biomark; 2018; 23(2):213-220. PubMed ID: 30198865
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Uterine Sarcoma with rAd-p53 (Gendicine) Followed by Chemotherapy: Clinical Study of TP53 Gene Therapy.
Xia Y; Du Z; Wang X; Li X
Hum Gene Ther; 2018 Feb; 29(2):242-250. PubMed ID: 29281902
[TBL] [Abstract][Full Text] [Related]
6. p53 gene therapy-based transarterial chemoembolization for unresectable hepatocellular carcinoma: A prospective cohort study.
Shen A; Liu S; Yu W; Deng H; Li Q
J Gastroenterol Hepatol; 2015 Nov; 30(11):1651-6. PubMed ID: 25968838
[TBL] [Abstract][Full Text] [Related]
7. Applications of Recombinant Adenovirus-p53 Gene Therapy for Cancers in the Clinic in China.
Xia Y; Li X; Sun W
Curr Gene Ther; 2020; 20(2):127-141. PubMed ID: 32951572
[TBL] [Abstract][Full Text] [Related]
8. Investigation on the Genomic Characterization of Uterine Sarcoma for rAd-
Xia Y; Wang L; Ma X; Li X
Hum Gene Ther; 2020 Aug; 31(15-16):881-890. PubMed ID: 32013587
[TBL] [Abstract][Full Text] [Related]
9. Recombinant Human p53 Adenovirus Injection (rAd-p53) Combined with Chemotherapy for 4 Cases of High-grade Serous Ovarian Cancer.
Qu H; Xia Y; Li X
Curr Gene Ther; 2020; 20(4):313-320. PubMed ID: 32851960
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated wild-type p53 gene transfer in combination with bronchial arterial infusion for treatment of advanced non-small-cell lung cancer, one year follow-up.
Guan YS; Liu Y; Zou Q; He Q; La Z; Yang L; Hu Y
J Zhejiang Univ Sci B; 2009 May; 10(5):331-40. PubMed ID: 19434759
[TBL] [Abstract][Full Text] [Related]
11. Trans-arterial p53-gene-embolization with gelatin sponge microparticles for hepatocellular carcinoma with BCLC stage B: single-center experience.
Liu Y; Zhang Y; Bautista D; Tang S; Zhou J; Li C; Zhao G
Cell Biochem Biophys; 2015 Jan; 71(1):99-104. PubMed ID: 25323562
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of endostar® combined with chemotherapy in patients with advanced soft tissue sarcomas.
Zhang LP; Liao XY; Xu YM; Yan LJ; Yan GF; Wang XX; Duan YZ; Sun JG
Asian Pac J Cancer Prev; 2013; 14(7):4255-9. PubMed ID: 23991986
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated p53 gene therapy in pediatric soft-tissue sarcoma cell lines: sensitization to cisplatin and doxorubicin.
Ganjavi H; Gee M; Narendran A; Freedman MH; Malkin D
Cancer Gene Ther; 2005 Apr; 12(4):397-406. PubMed ID: 15618970
[TBL] [Abstract][Full Text] [Related]
14. Clinical study of recombinant adenovirus-p53 (Adp53) combined with hyperthermia in advanced cancer (a report of 15 cases).
Zhang S; Xu G; Liu C; Xiao S; Sun Y; Su X; Cai Y; Li D; Xu B
Int J Hyperthermia; 2005 Nov; 21(7):631-6. PubMed ID: 16304714
[TBL] [Abstract][Full Text] [Related]
15. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of recombinant human adenovirus p53 combined with chemoradiotherapy in the treatment of recurrent nasopharyngeal carcinoma.
Ma WS; Ma JG; Xing LN
Anticancer Drugs; 2017 Feb; 28(2):230-236. PubMed ID: 27775992
[TBL] [Abstract][Full Text] [Related]
17. The First Approved Gene Therapy Product for Cancer Ad-p53 (Gendicine): 12 Years in the Clinic.
Zhang WW; Li L; Li D; Liu J; Li X; Li W; Xu X; Zhang MJ; Chandler LA; Lin H; Hu A; Xu W; Lam DM
Hum Gene Ther; 2018 Feb; 29(2):160-179. PubMed ID: 29338444
[TBL] [Abstract][Full Text] [Related]
18. Randomized, controlled phase II study of post-surgery radiotherapy combined with recombinant adenoviral human p53 gene therapy in treatment of oral cancer.
Liu S; Chen P; Hu M; Tao Y; Chen L; Liu H; Wang J; Luo J; Gao G
Cancer Gene Ther; 2013 Jun; 20(6):375-8. PubMed ID: 23722592
[TBL] [Abstract][Full Text] [Related]
19. A patient with a large intrathoracic malignant schwannoma who showed a complete clinical response to rAd-p53-combined with radiotherapy.
Liu K; Zhao J; Jiang H; Ma J; Tan J; Pei Y; Chen J
Anticancer Drugs; 2015 Sep; 26(8):902-6. PubMed ID: 26146864
[TBL] [Abstract][Full Text] [Related]
20. In Vitro and Clinical Studies of Gene Therapy with Recombinant Human Adenovirus-p53 Injection for Malignant Melanoma.
Shi SW; Li B; Dong Y; Ge Y; Qu X; Lu LG; Yuan YH; Li LJ; Li Y
Hum Gene Ther Clin Dev; 2019 Mar; 30(1):7-18. PubMed ID: 30618300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
